Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Early Phase 1
1(33.3%)
3Total
N/A(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06600529Not ApplicableRecruiting

Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder

Role: lead

NCT06524531Early Phase 1Recruiting

Pulsed RF Neuromodulation and Leukocyte-Rich PRP for Refractory Low Back Pain

Role: lead

NCT06453291Not ApplicableRecruiting

Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain

Role: lead

All 3 trials loaded